Surfactant replacement therapy. An update on applications.
Surfactant replacement therapy has been shown to be an effective and often life-saving treatment for newborn infants with respiratory distress syndrome (RDS). This article provides the clinician with an update regarding the various other applications of surfactant replacement therapy, as well as issues related to surfactant administration for the preparations approved for use in pediatric patients.
Dekowski
S A
SA
Division of Neonatology, Northwestern University Medical School, Chicago, Illinois, USA.
Holtzman
R B
RB
D002626:Chemistry, Pharmaceutical; D065630:Hernias, Diaphragmatic, Congenital; D006612:High-Frequency Ventilation; D006801:Humans; D007231:Infant, Newborn; D008471:Meconium Aspiration Syndrome / Q000188:drug therapy; D009569:Nitric Oxide / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy; D011663:Pulmonary Surfactants / Q000737:chemistry / Q000600:supply & distribution / Q000627:therapeutic use*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*
D011663:Pulmonary Surfactants; D009569:Nitric Oxide